3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
44
Recurrence
9
Sarcoma, Kaposi
2
Neoplasms, Plasma Cell
2
Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Burkitt Lymphoma
2
Acquired Immunodeficiency Syndrome
2
Plasmacytoma
1
Plasmablastic Lymphoma
1
Multi-centric Castleman's Disease
1
Malignant Plasma Cell Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Epstein-Barr Virus Infections
1
Interventions
pomalidomide
1
daratumumab
1
Immunotherapy, Adoptive
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Plasmacytoma
×
pomalidomide
×
90 days
×
Clear all
NCT01946477
2026-05-22
POM MM 014
Celgene
Phase 2
Completed
186 enrolled
17 charts